Linden Advisors’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Linden Advisors’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-60,928	Closed	-$60K	–	724
2021 Q2	$60K	Hold	60,928	–	–	﹤0.01%	796
2021 Q1	$54K	Buy	+60,928	New	+$68.6K	﹤0.01%	706

Other funds holding PKBOW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Linden Advisors's PKBOW Position: Q3 2021 in Review

Linden Advisors sold out of Peak Bio, Inc. Warrant (PKBOW) in Q3 2021, closing a stake of 60,928 shares — an estimated $60K sold.

Linden Advisors first reported a position in PKBOW in Q1 2021 and held it in 2 quarters. The position peaked at $60K in Q2 2021. 14 funds tracked by Wall St. Rank hold PKBOW as of Q3 2021.

Linden Advisors reported no remaining Peak Bio, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Linden Advisors sold 60,928 Peak Bio, Inc. Warrant shares in Q3 2021, an estimated $60K.
Linden Advisors first reported a position in Peak Bio, Inc. Warrant in Q1 2021 and held it in 2 quarters.
Linden Advisors's Peak Bio, Inc. Warrant position peaked at $60K in Q2 2021.
14 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.